Showing results (181-190 of 690) with videos related to
Sort By:
Pageof 69
Neuro-Oncology|May 28, 2010
Defective p53 antiangiogenic signaling in glioblastomaBenjamin Berger, David Capper, Dieter Lemke, et al.Expert Opinion on Emerging Drugs|May 15, 2013
Update on bevacizumab and other angiogenesis inhibitors for brain cancerMikael L Rinne, Eudocia Q Lee, Lakshmi Nayak, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 5, 2006
Exercise interest and preferences among patients diagnosed with primary brain cancerLee W Jones, Bebe Guill, Stephen T Keir, et al.Scientific Reports|May 31, 2020
Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound systemNathan McDannold, Yongzhi Zhang, Jeffrey G Supko, et al.Annals of Neurology|March 30, 2011
Bevacizumab does not increase the risk of remote relapse in malignant gliomaAntje Wick, Nils Dörner, Navina Schäfer, et al.Journal of Translational Medicine|May 2, 2016
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosisChristian Kleist, Elisabeth Mohr, Sadanand Gaikwad, et al.Deutsche Medizinische Wochenschrift (1946)|February 26, 2021
[Acute ischemic stroke and elevated troponin: Diagnostic work-up and therapeutic consequences]Niklas Grassl, Stefan Baumann, Mathieu Kruska, et al.Psycho-Oncology|August 25, 2006
Using the theory of planned behavior to understand the determinants of exercise intention in patients diagnosed with primary brain cancerLee W Jones, Bebe Guill, Stephen T Keir, et al.Cancer|November 21, 2015
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomasDavid Schiff, Annick Desjardins, Timothy Cloughesy, et al.Journal of Neuro-Oncology|May 6, 2009
Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patientsStephanie L Perry, Cindy Bohlin, David A Reardon, et al.Pageof 69